LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 95 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $790,297 | -62.1% | 537,617 | -18.0% | 0.00% | – |
| Q2 2023 | $2,086,153 | +59.1% | 656,023 | +18.1% | 0.00% | – |
| Q1 2023 | $1,311,051 | -68.8% | 555,530 | -54.2% | 0.00% | -100.0% |
| Q4 2022 | $4,207,631 | +49.0% | 1,212,574 | +214.8% | 0.00% | 0.0% |
| Q3 2022 | $2,824,000 | +115.1% | 385,220 | +91.3% | 0.00% | – |
| Q2 2022 | $1,313,000 | +39.5% | 201,407 | +8.1% | 0.00% | – |
| Q1 2022 | $941,000 | +16.7% | 186,356 | +79.0% | 0.00% | – |
| Q4 2021 | $806,000 | -75.4% | 104,112 | -48.5% | 0.00% | -100.0% |
| Q2 2021 | $3,281,000 | – | 202,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $156,056,000 | 45.49% |
| Foresite Capital Management IV, LLC | 13,282,181 | $102,804,000 | 21.15% |
| Apoletto Ltd | 15,093,969 | $116,827,000 | 14.55% |
| SB Management Ltd | 3,500,000 | $27,090,000 | 2.68% |
| HSG Holding Ltd | 3,045,997 | $23,576,000 | 2.11% |
| MIC Capital Management UK LLP | 1,320,000 | $10,217,000 | 1.95% |
| Alphabet Inc. | 5,865,125 | $45,396,000 | 1.10% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $12,754,000 | 0.80% |
| Adero Partners, LLC | 491,372 | $3,803,000 | 0.62% |
| Ergoteles LLC | 1,008,428 | $7,805,000 | 0.30% |